Café

© 2026 Longbridge｜Terms of Service Privacy Policy

Ionis Pharma

IONS

----

OverviewOverview NewsNews PostsPosts FinancialsFinancials ForecastForecast ValuationValuation ShareholdersShareholders ProfileProfile

LongbridgeAI

10 Health Care Stocks With Whale Alerts In Today’s Session
benzinga_article·2 hours ago
NVO-2.00%HIMS+3.35%
Ionis Maintains Buy Rating as Olezarsen’s sHTG Profile Outshines Rival; $86 Price Target Reaffirmed
Tip Ranks·1 day ago, 09:55 AM
IONS+3.44%
Pre-market hot trades in US stocks: Ionis Pharma pre-market down 10.21%; Fluence Energy pre-market up 7.26%
Price Alert·1 day ago, 06:42 AM
IONS+3.44%FLNC-1.64%
This Etsy Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Thursday
benzinga_article·Jul 16 at 06:15 AM
IONS+3.44%PNR-1.51%
Ionis to hold second quarter 2026 financial results webcast | IONS Stock News
StockTitan·Jul 14 at 10:05 PM
IONS+3.44%
Biogen Slumps As Alzheimer's Study Leaves 'More Questions Than Answers'
Unusual Whales·Jul 14 at 11:50 AM
BIIB+1.46%IONS+3.44%
Ionis Partner Biogen Presents Phase 2 CELIA Data at AAIC Demonstrating Meaningful Clinical Outcomes and Robust Tau Reduction with Diranersen in Early Alzheimer’s Disease | IONS Stock News
StockTitan·Jul 14 at 12:16 AM
BIIB+1.46%IONS+3.44%
Ionis doses first patient in Phase 1-2 trial of ION337 for Dravet syndrome
PUBT·Jul 13 at 06:00 AM
IONS+3.44%
Ionis Pharmaceuticals tumbles 9% as Phase 3 trial fails endpoint
US Stock Market Update·Jul 10 at 01:52 PM
IONS+3.44%
Ionis Pharmaceuticals Drops 8% in Trading as Phase 3 Trial Misses Primary Endpoint
US Stock Market Update·Jul 10 at 11:50 AM
IONS+3.44%
Weekly Buzz: JNJ, VERA Get FDA Nod; VRTX Snaps Up CRNX; MSLE Aces DMD Trial; IONS Misses Key Goal
rttnews·Jul 10 at 11:15 AM
ABBV+1.43%VANI0.00%
Ionis Pharmaceuticals tumbles 9% as Phase 3 trial misses primary endpoint
US Stock Market Update·Jul 10 at 10:31 AM
IONS+3.44%